bicalutimide | 10:00 antineoplastic agents | FDA Pregnancy Category X | DailyMed; DrugBank | ||||
bleomycin | 10:00 antineoplastic agents |
yes
|
IARC Group 2B; FDA Pregnancy Category D | DailyMed; DrugBank | |||
bortezomib | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
brentuximab vedotin | 10:00 antineoplastic agents |
yes
|
Conjugated monoclonal antibody; FDA Pregnancy Category D | DailyMed; DrugBank | |||
busulfan | 10:00 antineoplastic agents |
yes
|
IARC Group 1 carcinogen; FDA Pregnancy Category D | DailyMed; DrugBank | |||
cabazitaxel | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
capecitabine | 10:00 antineoplastic agents |
yes
|
Metabolized to 5-fluorouracil; FDA Pregnancy Category D | DailyMed; DrugBank | |||
carboplatin | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
carmustine | 10:00 antineoplastic agents |
yes
|
IARC Group 2A carcinogen; FDA Pregnancy Category D | DailyMed; DrugBank | |||
chlorambucil | 10:00 antineoplastic agents |
yes
|
IARC Group 1 carcinogen; FDA Pregnancy Category D | DailyMed; DrugBank | |||
cisplatin | 10:00 antineoplastic agents |
yes
|
IARC Group 2A carcinogen; FDA Pregnancy Category D | DailyMed; DrugBank | |||
cladribine | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
clofarabine | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
crizotinib | 10:00 antineoplastic agents | FDA Pregnancy Category D | DailyMed | ||||
cyclophosphamide | 10:00 antineoplastic agents |
yes
|
IARC Group 1 carcinogen; FDA Pregnancy Category D | DailyMed; Drugbank | |||
cytarabine | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
dacarbazine | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category C | DailyMed; Drugbank | |||
dactinomycin | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; DrugBank | |||
dasatinib | 10:00 antineoplastic agents |
yes
|
FDA Pregnancy Category D | DailyMed; Drugbank | |||
daunorubicin | 10:00 antineoplastic agents |
yes
|
IARC Group 2B, AKA daunomycin; FDA Pregnancy Category D |
DailyMed; Drugbank |
Tuesday, November 18, 2014
Hazardous Drugs bicalutimide to daunorubicin
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment